Home/Nykode Therapeutics/Professor Inger Sandlie
PI

Professor Inger Sandlie

Scientific Founder (Contributor to technology development)

Nykode Therapeutics

Nykode Therapeutics Pipeline

DrugIndicationPhase
VB10.16Human papillomavirus type 16 (HPV16)-positive cancersPhase 2
VB10.NEOLocally advanced and metastatic tumorsPhase 1b